982 related articles for article (PubMed ID: 18528183)
41. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
42. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
[TBL] [Abstract][Full Text] [Related]
43. Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.
Apostolova I; Wiemker R; Paulus T; Kabus S; Dreilich T; van den Hoff J; Plotkin M; Mester J; Brenner W; Buchert R; Klutmann S
Eur Radiol; 2010 Aug; 20(8):1868-77. PubMed ID: 20306084
[TBL] [Abstract][Full Text] [Related]
44. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K;
J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626
[TBL] [Abstract][Full Text] [Related]
45. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
46. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
[TBL] [Abstract][Full Text] [Related]
47. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
[TBL] [Abstract][Full Text] [Related]
48. FDG-PET and CT characterization of adrenal lesions in cancer patients.
Jana S; Zhang T; Milstein DM; Isasi CR; Blaufox MD
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):29-35. PubMed ID: 16193311
[TBL] [Abstract][Full Text] [Related]
49. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
[TBL] [Abstract][Full Text] [Related]
50. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
51. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
[TBL] [Abstract][Full Text] [Related]
52. FDG-PET/CT for diagnosis of primary ovarian cancer.
Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
[TBL] [Abstract][Full Text] [Related]
53. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.
Nguyen NC; Kaushik A; Wolverson MK; Osman MM
Acta Oncol; 2011 Jun; 50(5):670-7. PubMed ID: 21247262
[TBL] [Abstract][Full Text] [Related]
54. Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
Daouk J; Leloire M; Fin L; Bailly P; Morvan J; El Esper I; Saidi L; Moullart V; François G; Jounieaux V; Meyer ME
Acta Radiol; 2011 Jul; 52(6):651-7. PubMed ID: 21511870
[TBL] [Abstract][Full Text] [Related]
55. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
[TBL] [Abstract][Full Text] [Related]
56. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
57. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
58. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128
[TBL] [Abstract][Full Text] [Related]
59. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
[TBL] [Abstract][Full Text] [Related]
60. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
